Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

View ORCID ProfileJean-Claude Tardif, Nadia Bouabdallaoui, Philippe L. L’Allier, Daniel Gaudet, Binita Shah, Michael H. Pillinger, Jose Lopez-Sendon, Protasio da Luz, Lucie Verret, Sylvia Audet, Jocelyn Dupuis, View ORCID ProfileAndré Denault, Martin Pelletier, Philippe A. Tessier, Sarah Samson, Denis Fortin, Jean-Daniel Tardif, David Busseuil, Elisabeth Goulet, Chantal Lacoste, Anick Dubois, Avni Y. Joshi, David D. Waters, Priscilla Hsue, Norman E. Lepor, Frédéric Lesage, Nicolas Sainturet, Eve Roy-Clavel, Zohar Bassevitch, Andreas Orfanos, Jean C. Grégoire, Lambert Busque, Christian Lavallée, Pierre-Olivier Hétu, Jean-Sébastien Paquette, Sylvie Levesque, Mariève Cossette, View ORCID ProfileAnna Nozza, Malorie Chabot-Blanchet, View ORCID ProfileMarie-Pierre Dubé, Marie-Claude Guertin, Guy Boivin, for the COLCORONA Investigators
doi: https://doi.org/10.1101/2021.01.26.21250494
Jean-Claude Tardif
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Claude Tardif
  • For correspondence: jean-claude.tardif@icm-mhi.org
Nadia Bouabdallaoui
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe L. L’Allier
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Gaudet
2Ecogene-21 and Department of Medicine, Université de Montréal, Chicoutimi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Binita Shah
3New York University Grossman School of Medicine, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael H. Pillinger
3New York University Grossman School of Medicine, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose Lopez-Sendon
4H La Paz, IdiPaz, UAM, Ciber-CV Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Protasio da Luz
5Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucie Verret
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia Audet
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jocelyn Dupuis
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Denault
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for André Denault
Martin Pelletier
13Centre Hospitalier Universitaire de Québec and Université Laval
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe A. Tessier
13Centre Hospitalier Universitaire de Québec and Université Laval
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Samson
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Fortin
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Daniel Tardif
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Busseuil
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Goulet
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Lacoste
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anick Dubois
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avni Y. Joshi
6Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David D. Waters
7San Francisco General Hospital, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priscilla Hsue
7San Francisco General Hospital, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman E. Lepor
8Cedars-Sinai Heart Institute, Geffen School of Medicine-UCLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédéric Lesage
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Sainturet
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eve Roy-Clavel
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zohar Bassevitch
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Orfanos
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean C. Grégoire
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lambert Busque
9Hopital Maisonneuve-Rosemont, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Lavallée
9Hopital Maisonneuve-Rosemont, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Olivier Hétu
10Centre Hospitalier de l’Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Sébastien Paquette
11Université Laval, Quebec City
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Levesque
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariève Cossette
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Nozza
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Nozza
Malorie Chabot-Blanchet
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Pierre Dubé
1Montreal Heart Institute, Université de Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie-Pierre Dubé
Marie-Claude Guertin
12Montreal Health Innovations Coordinating Center, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Boivin
13Centre Hospitalier Universitaire de Québec and Université Laval
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Evidence suggests the role of an inflammatory storm in COVID-19 complications. Colchicine is an orally administered, anti-inflammatory medication beneficial in gout, pericarditis and coronary disease.

Methods We performed a randomized, double-blind trial involving non-hospitalized patients with COVID-19 diagnosed by polymerase chain reaction (PCR) testing or clinical criteria. The patients were randomly assigned to receive colchicine (0.5 mg twice daily for 3 days and once daily thereafter) or placebo for 30 days. The primary efficacy endpoint was the composite of death or hospitalization for COVID-19.

Results A total of 4488 patients were enrolled. The primary endpoint occurred in 4.7% of the patients in the colchicine group and 5.8% of those in the placebo group (odds ratio, 0.79; 95.1% confidence interval (CI), 0.61 to 1.03; P=0.08). Among the 4159 patients with PCR-confirmed COVID-19, the primary endpoint occurred in 4.6% and 6.0% of patients in the colchicine and placebo groups, respectively (odds ratio, 0.75; 95% CI, 0.57 to 0.99; P=0.04). In these patients with PCR-confirmed COVID-19, the odds ratios were 0.75 (95% CI, 0.57 to 0.99) for hospitalization due to COVID-19, 0.50 (95% CI, 0.23 to 1.07) for mechanical ventilation, and 0.56 (95% CI, 0.19 to 1.66) for death. Serious adverse events were reported in 4.9% and 6.3% in the colchicine and placebo groups (P=0.05); pneumonia occurred in 2.9% and 4.1% of patients (P=0.02). Diarrhea was reported in 13.7% and 7.3% in the colchicine and placebo groups (P<0.0001).

Conclusion Among non-hospitalized patients with COVID-19, colchicine reduces the composite rate of death or hospitalization. (COLCORONA ClinicalTrials.gov number: NCT04322682)

Competing Interest Statement

JCT reports grants from Government of Quebec, National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (NIH), the Montreal Heart Institute Foundation, from Bill and Melinda Gates Foundation, Amarin, Esperion, Ionis, Servier, RegenXBio; personal fees from Astra Zeneca, Sanofi, Servier; and personal fees and minor equity interest from Dalcor. In addition, JCT's institution has submitted a patent Methods of treating a coronavirus infection using Colchicine pending and a patent Early administration of low-dose colchicine after myocardial infarction pending. JCT has waived his rights in all patents related to colchicine and does not stand to benefit financially if colchicine becomes used as a treatment for COVID-19. MPD and JCT have a patent Methods for Treating or Preventing Cardiovascular Disorders and Lowering Risk of Cardiovascular Events issued to Dalcor, no royalties received, a patent Genetic Markers for Predicting Responsiveness to Therapy with HDL-Raising or HDL Mimicking Agent issued to Dalcor, no royalties received, and a patent Methods for using low dose colchicine after myocardial infarction with royalties paid to Invention assigned to the Montreal Heart Institute. NB reports personal fees from AstraZeneca; BS reports grants from NIH NHLBI; MHP reports grants from Hikma Pharmaceuticals, Horizon Therapeutics, and personal fees from Horizon Therapeutics; JLS reports grants from Bayer, Pfizer, Amgen, Boheringer Ingelheim and personal fees from Menarini; AYD reports personal fees from CAE Healthcare and Masimo, grants from Edwards; PH reports grants from NIH, Montreal Heart Institute, Gilead, and other from Merck; AO reports grants from the COVID-19 Therapeutics Accelerator; JSP reports personal fees from Universite Laval; MPD reports personal fees and other from Dalcor and personal fees from GlaxoSmithKline, other from AstraZeneca, Pfizer, Servier, Sanofi. Other authors have nothing to declare.

Clinical Trial

NCT04322682

Funding Statement

The study was funded by the Government of Quebec, the Bill and Melinda Gates Foundation, the National Institutes of Health and philanthropist Sophie Desmarais. The study medication and matching placebo were provided by Pharmascience (Montreal), which had no role in the design or conduct of the trial or the preparation or review of the manuscript. The first author (JCT) and lead statistician (MCG) prepared the first draft of the manuscript, had full access to the trial database, generated statistical analyses, made the decision to submit the manuscript for publication, and assume responsibility for the accuracy and completeness of the data and analyses and for the fidelity to the protocol.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The protocol was approved by the Montreal Heart Institute research ethics committee and all institutional review boards at all centers involved in the 6 countries that participated in the trial.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be made available through vivli.org.

http://www.vivli.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 27, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
Jean-Claude Tardif, Nadia Bouabdallaoui, Philippe L. L’Allier, Daniel Gaudet, Binita Shah, Michael H. Pillinger, Jose Lopez-Sendon, Protasio da Luz, Lucie Verret, Sylvia Audet, Jocelyn Dupuis, André Denault, Martin Pelletier, Philippe A. Tessier, Sarah Samson, Denis Fortin, Jean-Daniel Tardif, David Busseuil, Elisabeth Goulet, Chantal Lacoste, Anick Dubois, Avni Y. Joshi, David D. Waters, Priscilla Hsue, Norman E. Lepor, Frédéric Lesage, Nicolas Sainturet, Eve Roy-Clavel, Zohar Bassevitch, Andreas Orfanos, Jean C. Grégoire, Lambert Busque, Christian Lavallée, Pierre-Olivier Hétu, Jean-Sébastien Paquette, Sylvie Levesque, Mariève Cossette, Anna Nozza, Malorie Chabot-Blanchet, Marie-Pierre Dubé, Marie-Claude Guertin, Guy Boivin, for the COLCORONA Investigators
medRxiv 2021.01.26.21250494; doi: https://doi.org/10.1101/2021.01.26.21250494
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
Jean-Claude Tardif, Nadia Bouabdallaoui, Philippe L. L’Allier, Daniel Gaudet, Binita Shah, Michael H. Pillinger, Jose Lopez-Sendon, Protasio da Luz, Lucie Verret, Sylvia Audet, Jocelyn Dupuis, André Denault, Martin Pelletier, Philippe A. Tessier, Sarah Samson, Denis Fortin, Jean-Daniel Tardif, David Busseuil, Elisabeth Goulet, Chantal Lacoste, Anick Dubois, Avni Y. Joshi, David D. Waters, Priscilla Hsue, Norman E. Lepor, Frédéric Lesage, Nicolas Sainturet, Eve Roy-Clavel, Zohar Bassevitch, Andreas Orfanos, Jean C. Grégoire, Lambert Busque, Christian Lavallée, Pierre-Olivier Hétu, Jean-Sébastien Paquette, Sylvie Levesque, Mariève Cossette, Anna Nozza, Malorie Chabot-Blanchet, Marie-Pierre Dubé, Marie-Claude Guertin, Guy Boivin, for the COLCORONA Investigators
medRxiv 2021.01.26.21250494; doi: https://doi.org/10.1101/2021.01.26.21250494

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5199)
  • Forensic Medicine (3)
  • Gastroenterology (193)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (211)
  • Health Informatics (690)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5793)
  • Intensive Care and Critical Care Medicine (355)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1986)
  • Radiology and Imaging (342)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)